FTT.AX - Factor Therapeutics Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
30/06/2017
30/06/2016
Operating expenses
Research development
81.201
81.201
7,429
6,536
903.027
Selling general and administrative
379.666
379.666
2,587
2,384
2,079
Total operating expenses
837.474
837.474
10,336
9,534
4,698
Operating income or loss
-837.474
-837.474
-10,336
-9,534
-4,698
Interest expense
3.038
3.038
10.729
10.199
9.988
Total other income/expenses net
2,503
2,503
-664.407
3,858
-7,015
Income before tax
1,669
1,669
-10,956
-5,594
-11,611
Income tax expense
0
0
0
0.242
0.972
Income from continuing operations
1,669
1,669
-10,956
-5,594
-11,612
Net income
1,669
1,669
-10,956
-5,594
-11,612
Net income available to common shareholders
1,669
1,669
-10,956
-5,594
-11,612
Basic EPS
-
-
-0.01
-0.01
-0.03
Diluted EPS
-
-
-0.01
-0.01
-0.03
Basic average shares
-
-
803,476
736,071
384,742
Diluted average shares
-
-
803,476
736,071
384,742
EBITDA
-
1,675
-10,904
-5,541
-11,558